Syntactx: Hancock Jaffe Engages Syntactx for VenoValve U.S. Pivotal Trial
Hancock Jaffe Laboratories, Inc. today announced that it has engaged Syntactx LLC to assist Hancock Jaffe with the VenoValve U.S. pivotal trial.
Read full article »
Syntactx is a clinical research organization that offers clinical trials, medical device development, and regulatory consulting services.
Read more